Free Trial

Replimune Group (REPL) Earnings Date, Estimates & Call Transcripts

Replimune Group logo
$11.23 +0.28 (+2.56%)
(As of 11/20/2024 ET)

Replimune Group Latest Earnings Summary

Upcoming
Earnings Date
Feb. 13Estimated
Actual EPS
(Nov. 12)
-$0.68 Beat By $0.07
Consensus EPS
(Nov. 12)
-$0.75

Replimune Group issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.68, which beat analysts' consensus estimates of -$0.75 by $0.07. With a trailing EPS of -$3.05, Replimune Group's earnings are expected to grow next year, from ($3.02) to ($2.54) per share.

REPL Upcoming Earnings

Replimune Group's next earnings date is estimated for Thursday, February 13, 2025, based off prior year's reporting schedules.

Get Replimune Group Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Replimune Group and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

REPL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

REPL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Replimune Group Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.87-$0.80-$0.84
Q2 20242-$0.96-$0.80-$0.88
Q3 20242-$0.90-$0.85-$0.88
Q4 20243-$1.01-$0.74-$0.91
FY 20249-$3.74-$3.19-$3.50
Q1 20253-$0.85-$0.70-$0.77
Q2 20254-$0.87-$0.70-$0.79
Q3 20254-$0.88-$0.68-$0.75
Q4 20254-$0.90-$0.66-$0.78
FY 202515-$3.50-$2.74-$3.09
Q1 20262-$0.92-$0.92-$0.92
Q2 20262-$0.96-$0.89-$0.93
Q3 20262-$0.93-$0.61-$0.77
Q4 20262-$0.85-$0.61-$0.73
FY 20268($3.66)($3.03)($3.35)

Replimune Group Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/13/2025
(Estimated)
------- 
11/12/2024--$0.75-$0.68+$0.07-$0.68--
8/8/2024--$0.88-$0.78+$0.10-$0.78--  
5/16/2024Q4 2024-$0.86-$0.82+$0.04-$0.82--  
2/8/2024Q3 2024-$0.89-$0.77+$0.12-$0.77--    
11/7/2023Q2 2024-$0.80-$0.90 -$0.10-$0.90--  
8/3/2023Q1 2024-$0.80-$0.75+$0.05-$0.75--    
5/18/2023Q4 2023-$0.66-$0.74 -$0.08-$0.74--  
2/9/2023Q3 2023-$0.77-$0.69+$0.08-$0.69--  

Replimune Group Earnings - Frequently Asked Questions

Replimune Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates. Learn more on REPL's earnings history.

In the previous quarter, Replimune Group (NASDAQ:REPL) reported ($0.68) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.75) by $0.07. Learn more on analysts' earnings estimate vs. REPL's actual earnings.

Replimune Group (NASDAQ:REPL) has a recorded net income of -$215.79 million. REPL has generated -$3.05 earnings per share over the last four quarters.

Replimune Group's earnings are expected to grow from ($3.02) per share to ($2.54) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:REPL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners